Imperial College London

DrTriciaTan

Faculty of MedicineDepartment of Medicine

Visiting Professor
 
 
 
//

Contact

 

+44 (0)20 3313 8038t.tan

 
 
//

Location

 

6N6ECommonwealth BuildingHammersmith Campus

//

Summary

 

Summary

Dr Tricia Tan is a Consultant in Diabetes, Endocrinology and Metabolic Medicine at Imperial College London and NHS Trust. She possesses over 10 years’ experience in gut hormone research and physiological studies into the impact of gut hormones on weight and T2DM. She has completed several Phase I trials on the gut hormone analogues, which are being developed for the treatment of obesity. She is the director of the SAS Gut Hormone service, and her clinical research spans a wide gamut from the diagnosis and treatment of neuroendocrine tumours to diagnostic testing in Endocrine disorders.

Publications

Journals

Cegla J, Jones BJ, Howard J, et al., 2017, The preanalytical stability of glucagon as measured by liquid chromatography tandem mass spectrometry and two commercially available immunoassays, Annals of Clinical Biochemistry, Vol:54, ISSN:0004-5632, Pages:293-296

Conference

Ahmed A, Tharakan G, Purkayastha S, et al., 2017, Bariatric surgery outcomes in the over-60s: a single centre, observational study from 2007-2012, 8th Annual Scientific Meeting of the British-Obesity-and-Metabolic-Surgery-Society (BOMSS), WILEY-BLACKWELL, Pages:6-6, ISSN:0007-1323

Ahmed A, Tharakan G, Purkayastha S, et al., 2017, Management of post prandial hypoglycaemia using liraglutide - comprehensive profiling pre and post intervention, 8th Annual Scientific Meeting of the British-Obesity-and-Metabolic-Surgery-Society (BOMSS), WILEY-BLACKWELL, Pages:7-8, ISSN:0007-1323

Ahmed A, Tharakan G, Purkayastha S, et al., 2017, The role of increased glycemic variability and glucagon in the pathophysiology of postprandial hypoglycemia after RYGB, 8th Annual Scientific Meeting of the British-Obesity-and-Metabolic-Surgery-Society (BOMSS), WILEY-BLACKWELL, Pages:13-13, ISSN:0007-1323

Cegla J, Jones BJ, Gardiner JV, et al., 2017, RAMP2 Influences Glucagon Receptor Pharmacology via Trafficking and Signaling, 52nd Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), OXFORD UNIV PRESS INC, Pages:2680-2693, ISSN:0013-7227

More Publications